Publicaciones en colaboración con investigadores/as de Universidad de Navarra (39)

2022

  1. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199

  2. Consensus on the Definition of Control and Remission in Chronic Urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269

  3. Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14

  4. Onset of Nut Allergy in a Pediatric Cohort: Clinical and Molecular Patterns in the AFRUSEN Study

    Journal of investigational allergology & clinical immunology, Vol. 32, Núm. 4, pp. 270-281

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2018

  1. Oral immunotherapy with egg and milk: Changes in peripheral serum cytokines are not predictive factors for severe adverse reactions or for the final report

    Journal of Investigational Allergology and Clinical Immunology, Vol. 28, Núm. 1, pp. 24-28

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Angio-oedema without hives, IgE and omalizumab

    Clinical and Experimental Dermatology

  3. Heterogeneity in allergy to mollusks: A clinical-immunological study in a population from the north of Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 27, Núm. 4, pp. 252-260

  4. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

  2. Is the quantification of antigen-specific basophil activation a useful tool for monitoring oral tolerance induction in children with egg allergy?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 1, pp. 25-30

  3. Lipid transfer protein syndrome in a non-mediterranean area

    International Archives of Allergy and Immunology, Vol. 169, Núm. 3, pp. 181-188

  4. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis

    British Journal of Dermatology, Vol. 175, Núm. 6, pp. 1153-1165

2015

  1. Are all new allergens in TRUE Test® essential for a baseline set?

    Contact Dermatitis

  2. Dress induced by piperacillin-tazobactam in a child

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 3, Núm. 4, pp. 615-617

  3. Management of urticaria: Not too complicated, not too simple

    Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743

2014

  1. In vivo and in vitro testing with rAni s 1 can facilitate diagnosis of Anisakis simplex allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 6, pp. 431-438

2013

  1. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice

    Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228